Our team combines deep scientific expertise with decades of industry experience to accelerate innovation in drug discovery, bioanalysis, genomics, and proteomics. Trained at world-renowned institutions including MIT, NIH, MSKCC, Mount Sinai, Rutgers, and NYU, our scientists also bring leadership experience from leading biopharma companies such as Novartis, Sanofi, Merck, BMS/Celgene, and Boehringer Ingelheim.

We design and execute cellular and molecular assays to evaluate drug efficacy, investigate mechanisms of action, and monitor gene and protein expression in samples from cell cultures, animal models, and patients. Every project is guided by scientific rigor, innovation, and a collaborative approach that ensures impactful outcomes.

Strong partnerships are the foundation of scientific breakthroughs. By fostering trusted R&D collaborations with biotech, pharmaceutical, diagnostic, government, and academic partners, we deliver tailored solutions that advance precision medicine and support the development of life-saving therapies.